Evidence map›Paper›PMID 39781609›Full record

ArticleBiomarkers in medicine2025

Predictive value of neutrophil-to-lymphocyte ratio and MELD score for short-term survival of patients with HBV-DeCi.

Zhong Han, Liangshuai Qi, Sirui Chen, Jinfei Zhang, Xueliang Guo, Chunying Liang, Weiwei Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomarkers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhong HanDepartment of Laboratory Medicine, Shengzhou People's Hospital, Shengzhou Branch of the First Affiliated Hospital of Zhejiang University School of Medicine, the Shengzhou Hospital of Shaoxing University, Shengzhou, Zhejiang, China.
Liangshuai QiSchool of Laboratory Medicine, Bengbu Medical University, Bengbu, Anhui, China.
Sirui ChenSchool of Laboratory Medicine, Bengbu Medical University, Bengbu, Anhui, China.
Jinfei ZhangDepartment of Laboratory Medicine, Shengzhou People's Hospital, Shengzhou Branch of the First Affiliated Hospital of Zhejiang University School of Medicine, the Shengzhou Hospital of Shaoxing University, Shengzhou, Zhejiang, China.
Xueliang GuoDepartment of Internal Medicine, Shengzhou People's Hospital, Shengzhou Branch of the First Affiliated Hospital of Zhejiang University School of Medicine, the Shengzhou Hospital of Shaoxing University, Shengzhou, Zhejiang, China.
Chunying LiangDepartment of Pharmacy, XinChang Hospital of Chinese Medicine, XinChang, Zhejiang, China.
Weiwei ZhengDepartment of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe prognostic value of neutrophil-to-lymphocyte ratio (NLR) combined with Model for End-Stage Liver Disease (MELD) score was evaluated for hepatitis B virus-associated decompensated cirrhosis (HBV-DeCi).

methodsThe 30-day mortality of 166 hBV-DeCi patients was examined. Receiver operating characteristic curve analysis and multivariate regression analysis were used to assess the performance of NLR for prediction of poor outcomes.

resultsThe 30-day mortality rate was 10.2% (17/166). NLR was significantly lower in survivors than in non-survivors, and could be used for prognosis prediction in HBV-DeCi patients. Area under the curve was higher for NLR combined with MELD score than for each factor alone. (MELD score, AUC:0.864、NLR, AUC:0.781, Combined, AUC:0.920) The Odds ratio of MELD score is lower than NLR.(MELD score:1.447&NLR:1.745).

conclusionsThe findings demonstrate that NLR combined with MELD score has a high prognostic value for HBV-DeCi patients.

Indexed as

End Stage Liver DiseaseHepatitis BLiver CirrhosisLymphocytesNeutrophilsAdultAgedArea Under CurveFemaleHepatitis B virusHumansMaleMiddle AgedPredictive Value of TestsPrognosisROC CurveDecompensated cirrhosishepatitis B virusMELD scoremortalityneutrophil-to-lymphocyte ratio

Identifiers

PMID39781609
PMCPMC11749384

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.